Title : Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.

Pub. Date : 2011 May 30

PMID : 21215737






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. benzyloxycarbonylleucyl-leucyl-leucine aldehyde aldo-keto reductase family 1 member B1 Ictalurus punctatus
2 Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Bortezomib aldo-keto reductase family 1 member B1 Ictalurus punctatus
3 The present study investigated the effect of bortezomib and MG-132 on the expression of AKR1C1-1C4, AKR1B1, and AKR1B10 in colon cancer cell lines HT-29 and SW-480. Bortezomib aldo-keto reductase family 1 member B1 Ictalurus punctatus
4 The present study investigated the effect of bortezomib and MG-132 on the expression of AKR1C1-1C4, AKR1B1, and AKR1B10 in colon cancer cell lines HT-29 and SW-480. benzyloxycarbonylleucyl-leucyl-leucine aldehyde aldo-keto reductase family 1 member B1 Ictalurus punctatus